DrugPatentWatch Database Preview
Drugs in Development Information for Larazotide
» See Plans and Pricing
What is the development status for investigational drug Larazotide?
Larazotide is an investigational drug.
There have been 4 clinical trials for Larazotide.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2018.
The most common disease conditions in clinical trials are Celiac Disease and [disabled in preview]. The leading clinical trial sponsors are Alba Therapeutics, Innovate Biopharmaceuticals, and Teva Pharmaceuticals USA.
There is one US patent protecting this investigational drug and twelve international patents.
Summary for Larazotide
| US Patents | 1 |
| International Patents | 12 |
| US Patent Applications | 1 |
| WIPO Patent Applications | 17 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2018-10-01) |
| Vendors | 8 |
Recent Clinical Trials for Larazotide
| Title | Sponsor | Phase |
|---|---|---|
| Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Treatment of Celiac Disease | Innovate Biopharmaceuticals | Phase 3 |
| A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease | Teva Pharmaceuticals USA | Phase 2 |
| A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease | Alba Therapeutics | Phase 2 |
Clinical Trial Summary for Larazotide
Top disease conditions for Larazotide
Top clinical trial sponsors for Larazotide
US Patents for Larazotide
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Larazotide | Start Trial | Larazotide acetate compositions | Alba Therapeutics Corporation (Baltimore, MD) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Larazotide
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Larazotide | Australia | 2008327846 | 2027-11-21 | Start Trial |
| Larazotide | Australia | 2011201848 | 2027-11-21 | Start Trial |
| Larazotide | Canada | 2707007 | 2027-11-21 | Start Trial |
| Larazotide | China | 101918429 | 2027-11-21 | Start Trial |
| Larazotide | China | 102241739 | 2027-11-21 | Start Trial |
| Larazotide | European Patent Office | 2062909 | 2027-11-21 | Start Trial |
| Larazotide | European Patent Office | 2222691 | 2027-11-21 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
